about
Integration of 'omics' data in aging research: from biomarkers to systems biologySerine, glycine and one-carbon units: cancer metabolism in full circleIsocitrate dehydrogenase mutations: new opportunities for translational researchMetabolic control of cancer cell stemness: Lessons from iPS cellsSuppression of Cytosolic NADPH Pool by Thionicotinamide Increases Oxidative Stress and Synergizes with ChemotherapyUpregulation of glucose metabolism by NF-κB2/p52 mediates enzalutamide resistance in castration-resistant prostate cancer cells.MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer.New miRNA profiles accurately distinguish renal cell carcinomas and upper tract urothelial carcinomas from the normal kidneyPrioritizing candidate disease metabolites based on global functional relationships between metabolites in the context of metabolic pathways.Glioma cells with the IDH1 mutation modulate metabolic fractional flux through pyruvate carboxylaseThe effects of PGC-1α on the proliferation and energy metabolism of malignant endometrial cancer cells.Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.Functional expression of sodium-glucose transporters in cancer.Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth in miceOverexpression of ErbB2 renders breast cancer cells susceptible to 3-BrPA through the increased dissociation of hexokinase II from mitochondrial outer membrane.5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma.Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and ErkMetabolism modifications and apoptosis induction after Cellfood™ administration to leukemia cell linesAltered glutamine metabolism and therapeutic opportunities for lung cancer.Epigenetics and cancer metabolism.Parallels between embryo and cancer cell metabolism.Oncometabolomics in cancer research.The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics.Metabolic isoenzyme shifts in cancer as potential novel therapeutic targets.The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growth.Ameliorating effect of Kalpaamruthaa on altered energy metabolism in BCR-ABL(+) cell line induced leukemic mouse model.Vastatin, an Endogenous Antiangiogenesis Polypeptide That Is Lost in Hepatocellular Carcinoma, Effectively Inhibits Tumor Metastasis.MicroRNA: a connecting road between apoptosis and cholesterol metabolism.The P2RY2 Receptor Induces Carcinoma Cell Migration and EMT Through Cross-Talk With Epidermal Growth Factor Receptor.Identifying novel targets in renal cell carcinoma: design and synthesis of affinity chromatography reagents.Bead Based Proteome Enrichment Enhances Features of the Protein Elution Plate (PEP) for Functional Proteomic ProfilingRegulation of hepatic stellate cell proliferation and activation by glutamine metabolismPKM2, a Central Point of Regulation in Cancer Metabolism.Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancerc-Myc and cancer metabolism.Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.PGC-1alpha levels correlate with survival in patients with stage III NSCLC and may define a new biomarker to metabolism-targeted therapy.Memantine induces apoptosis and inhibits cell cycle progression in LNCaP prostate cancer cells.Primary brain tumors, delta 24 and tumor metabolism. Interview by Rona Williamson.
P2860
Q26786552-79DF6BFF-D268-42AB-B0B4-5A61152BDCDBQ26828610-9977E023-926B-4EA8-BB98-D14CB736D9C5Q27001014-78AD8AA0-78E1-4421-B35E-A733920B0ED2Q28081608-7893A02A-79D1-47CB-9977-9C42665EB66FQ28265635-5121AA89-3242-439A-BC32-F403B6236164Q34411599-9D3884E4-58D0-4C85-B313-AB9CB4252562Q34439115-BD5E0852-AA9B-477F-8DFF-300371EE56B1Q35118634-FC465F21-FE0B-40B6-AC73-CAC9BA12548AQ35231088-19DEAE52-30E4-4CC9-8CCB-2AB4F94E9069Q35268977-F65D6FF4-A166-4692-B79F-E0D7611A2874Q35444428-883DAE91-CBB8-4770-80F4-3FCE642470F5Q35691988-F2A2025D-6097-43D6-8310-B12625A51EF7Q35909986-1581FD86-F2A8-484F-A590-2DCEAA0BBA27Q36175385-2A414603-BCDD-4D2F-93C9-141FECD4847BQ36524759-00664657-C0DC-476C-AD03-EA8FD9A8DFD5Q36561571-6783B3BA-5316-49DB-A05B-A071CF22E0D2Q36939981-D4EA361A-9FA3-44EC-A7E0-526579BD2F4BQ37030873-35B43D43-1F74-4AB1-B82A-8A25AD6F690EQ37356696-474ED2B7-9CC3-48E0-AB94-E7216E7662F6Q37673339-577CA71B-D14C-4148-B1E6-7EB43C35E58BQ37699025-48D9C0A0-D4C6-4720-BBDF-A21A7553F8A3Q38091504-1627B20B-3108-47B8-945E-99D79983B8E2Q38132912-06BDD3F0-CDE5-4239-8BC0-E5E4C406045FQ38149124-C77E507A-B824-4633-BC40-CED5D088DDE0Q38268052-0153516F-451D-4C38-9DF1-16EA39F3D3FFQ38751306-902DE985-E79E-49F3-A21D-BECBDFE526BEQ38762570-3A778E8C-9390-448E-9152-56C83CE8886FQ38787495-3302CE65-D86C-4AFC-B4C7-1151B3D7AD12Q38815056-67F9676F-56DC-4167-BE06-9D6C79508EEEQ38829837-2BC58C9B-C8DD-4B5C-9BD2-763D23CC5483Q39037619-1AA18121-CBC4-429B-A0A2-2949B5703CC3Q40872824-E4C2EEFE-1307-4A5B-BA48-716FA85786FDQ41349258-C5DED286-FF8F-475F-9742-A41EBAACE704Q41669982-373DE995-BE2E-4879-BA34-5659D661D7CBQ42339119-C6EB9697-8E4F-4890-9512-82C872756675Q42351696-5D254273-5659-404F-925B-2D2980422C3DQ46753862-0A5B334D-C58F-4917-A832-A603B785B4BBQ47129288-5CD6FC10-A133-41F3-A2D4-9C64BCAE4FEEQ47309094-E831667D-DE59-44E8-9223-47CF22A8FF03Q48101983-9B2B8BB3-EEF0-4CDB-9070-7CF9AB070976
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Targeting cancer metabolism.
@ast
Targeting cancer metabolism.
@en
type
label
Targeting cancer metabolism.
@ast
Targeting cancer metabolism.
@en
prefLabel
Targeting cancer metabolism.
@ast
Targeting cancer metabolism.
@en
P2093
P2860
P1476
Targeting cancer metabolism.
@en
P2093
Beverly A Teicher
Lee J Helman
W Marston Linehan
P2860
P304
P356
10.1158/1078-0432.CCR-12-2587
P407
P577
2012-10-01T00:00:00Z